Raynovent Announces Receiving of Certificate of Invention Patent in United States in Japan

Previous:Raynovent Announces Receiving of Certificate of Invention Patent in United States

Next:Raynovent Announces Ethical Approval for Phase 1b /2a Clinical Trial of ZSP1601, a Category 1 Drug in Development for The Treatment of NASH.